ResMed (NYSE: RMD) finds itself in an investment limbo as revolutionary weight loss drugs create both immediate opportunities and long-term existential questions for the sleep apnea device maker.
ResMed (RMD) shares fell in the premarket on Wednesday after Morgan Stanley downgraded the respiratory device maker, citing ...
Connected sleep devicemaker ResMed today released the AirSense 11, its latest CPAP machine iteration, which includes a host of new features to treat obstructive sleep apnea. The new machine has many ...
TORONTO, ON / ACCESSWIRE / November 6, 2024 / Air Voel, a leading provider of CPAP solutions in Canada, is proud to announce the expansion of its product line with the latest CPAP machines from ResMed ...
The newly acquired software from Somnoware will slot in just ahead of ResMed’s existing care management platforms: AirView, which connects to ResMed’s sleep and ventilation devices to help monitor ...
SAN DIEGO, Dec. 08, 2025 (GLOBE NEWSWIRE) -- Resmed (NYSE: RMD, ASX: RMD), the leading health technology company focused on sleep, breathing and care delivered in the home, today announced it has ...
In just the fourth quarter of its 2022 fiscal year, ResMed raked in between $60 million and $70 million in CPAP sales directly related to the gap left by the Philips recall, the company said. (ResMed) ...
ResMed Inc. (NYSE:RMD) is one of the most undervalued large cap stocks to buy according to analysts. On June 1, ResMed finalized its acquisition of Noctrix Health, a medical device company known for ...
Loud snoring at night. Pauses in breathing followed by gasps for air while you're asleep. Excessive daytime fatigue. Frequent nodding off in front of the TV or even when behind the wheel of a ...
Please provide your email address to receive an email when new articles are posted on . ResMed CPAP masks that contain magnets are being recalled due to possible magnetic interference with medical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results